WO2025141467 - SOLID STATE FORMS OF LORUNDROSTAT AND PROCESS THEREOF
National phase entry is expected:
Publication Number
WO/2025/141467
Publication Date
03.07.2025
International Application No.
PCT/IB2024/063134
International Filing Date
23.12.2024
Title **
[English]
SOLID STATE FORMS OF LORUNDROSTAT AND PROCESS THEREOF
[French]
FORMES À L'ÉTAT SOLIDE DE LORUNDROSTAT ET PROCÉDÉ ASSOCIÉ
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
MUTHUSAMY, Anantha Rajmohan
RENGARAJ, Prathap
S, Azhaguraja
SINGH, Amit
SOMASUNDARAM, Meenakshi Sundaram
Priority Data
202311088845
26.12.2023
IN
202411010868
16.02.2024
IN
202411037135
10.05.2024
IN
202411095723
04.12.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2558 | |
| EPO | Filing, Examination, Granting | 12785 | |
| Japan | Filing, Examination, Granting | 2422 | |
| South Korea | Filing, Examination, Granting | 2643 | |
| USA | Filing, Examination, Granting | 8340 |
Total:
28,748
Contact Us
Abstract[English]
The present disclosure relates to Lorundrostat solid state forms, in embodiments crystalline polymorphs or salts of Lorundrostat, particularly Lorundrostat hydrobromide, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.[French]
La présente divulgation concerne des formes à l'état solide de lorundrostat, dans des modes de réalisation, des polymorphes cristallins ou des sels de lorundrostat, en particulier du bromhydrate de lorundrostat, des procédés de préparation de ceux-ci, des compositions pharmaceutiques de ceux-ci, et des méthodes d'utilisation de ceux-ci.